ArticleAnnals of hematology2024
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma.
Scott R Goldsmith et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleAnnals of hematology2024
Scott R Goldsmith et al.PubMed ↗Publisher ↗
No numbers read from the abstract.